Oragenics Inc
OGEN· NYSE
OGENOragenics Inc
Filed Mar 14, 2025 · 10-K · 73 days after period end · 0001493152-25-010389
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | — |
| Net Income | -$3.35M | -$12.75M | -$2.24M | -$2.29M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 14, 2025 · 73 d after period end
